Ganglioside treatment of acute Trypanosoma cruzi infection in mice promotes long-term survival and parasitological cure

Annals of Tropical Medicine and Parasitology

Volumn 93, Issue 4, 1999, Pages 341-350

  Bronia, D H ^a   Pereira, B M I ^a   Lujan H D ^a   Fretes, R E ^a   Fernandez A ^a   Paglini, P A ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; LAMPID; NIFURTIMOX; PHOSPHOLIPASE A2; REFLEXAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; INTRAMUSCULAR DRUG ADMINISTRATION; MEMBRANE STABILIZATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SURVIVAL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALIA; MAMMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0032812376     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1999.11813430     Document Type: Article

References (53)

1. Almeida, I. C., Ferguson, M. A., Schenkman, S. & Travassos, L. R. (1994). Lytic anti-α-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochemical Journal, 304, 793-802.
2. Andrade, S. G., Magalhaes, J. B. & Pontes, A. L. (1985). Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bulletin of the World Health Organization, 63, 721-726.
3. Andrews, N. W. (1990). Trypanosoma cruzi: Mechanisms of cell-invasion and intracellular survival. Experimental Parasitology, 71, 241-244.
4. Andrews, N. W. (1994). The acid-active hemolysin of Trypanosoma cruzi. Brazilian Journal of Medical and Biological Research, 27, 471-475.
5. Andrews, N. W., Schenkman, S., Ley, V., Whitlow, M. B., Robbins, E. S. & Nussenzweig, V. (1988). Trypanosoma cruzi: Mechanisms of cell-invasion and intracellular survival. Memórias do Instituto Oswaldo Cruz, 83, 452-455.
6. Andrews, N. W., Abrams, C. K., Slatin, S. L. & Griffiths, G. (1990). A T. cruzi-secreted protein immunologically related to the complement component C9: Evidence for membrane pore forming activity at low pH. Cell, 61, 1277-1287.
7. Arni, R. K. & Ward, R. J. (1996). Phospholipase A2: A structural review. Toxicon, 34, 827-841.
8. Avila, J. L., Rojas, M. & Avila, A. (1998). Increase in asialoganglioside- And monosialoganglioside-reactive antibodies in chronic Chagas' disease patients. American Journal of Tropical Medicine and Hygiene, 58, 338-342.
9. Barreto-Bergter, E., Vermelho, A. B., Hogge, L. & Gorin, P. A. (1985). Glycolipid components of epimastigote forms of Trypanosoma cruzi. Comparative and Biochemical Physiology. B, Comparative Biochemistry, 80, 543-545.
10. Barreto-Bergter, E., Vermelho, A. B., Hartmann, R., Pohlentz, G., Klein, R. A. & Egge, H. (1992). Structural characterization of neutral glycosphingolipids from Trypanosoma cruzi. Molecular and Biochemical Parasitology, 51, 263-270.
11. Bergelson, L. D. (1995). Serum gangliosides as endogenous immunomodulators. Immunology Today, 16, 483-486.
12. Bestetti, R. B., Pinto, L. Z., Soares, E. G., Muccillo, G. & Oliveira, J. S. (1991). Changes in electrocardiographic patterns at different stages of Chagas' heart disease in rats. Clinical Sciences, 80, 33-37.
13. Bestetti, R. B., Oliveira, J. S. M., Coutinho-Netto, J. & Pinto, L. Z. (1995). Beneficial effects of gangliosides on the natural history of acute chagasic myocarditis in rats. Cardiovascular Pathology, 4, 203-206.
14. Braun-Breton, C., Blisnick, T., Morales-Betoulle, M. E., Barale, J. C. & Langsley, G. (1994). Malaria parasites: Enzymes involved in red blood cell invasion. Journal of Medical and Biological Research, 27, 363-367.
15. Britto, C., Cardoso, M. A., Vanni, C. M., Hasslocher-Moreno, A., Xavier, S. S., Oelemann, W., Santoro, A., Pirmez, C., Morel, C. M. & Wincker, P. (1995). Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation. Parasitology, 110, 241-247.
16. Burleigh, B. A. & Andrews, N. W. (1995). The mechanisms of Trypanosoma cruzi invasion of mammalian cells. Annual Review of Microbiology, 49, 175-200.
17. Calderon, R. O., Aguerri, A. M. & Bronia, D. H. (1986). Trypanosoma cruzi: Variable fusogenic ability by different growth phases of the epimastigote form. Experimental Parasitology, 62, 453-455.
18. Calderon, R. O., Lujan, H. D., Aguerri, A. M. & Bronia, D. H. (1989). Trypanosoma cruzi: Involvement of proteolytic activity during cell fusion induced by epimastigote form. Molecular and Cellular Biochemistry, 86, 189-200.
19. Correa, S. G., Rivero, V. E., Yranzo-Volonte, N., Romero Piffinguer, M., Ferro, M. E. & Riera, C. M. (1993). Effect of gangliosides in the autoimmune response induced by liposome-associated antigens. Autoimmunity, 15, 195-200.
20. Dennis, E. A., Deems, R. A. & Yu, L. (1992). Extracellular phospholipase A2. Advances in Experimental Medicine and Biology, 318, 35-39.
21. Dvorak, J. A. & Howe, C. L. (1977). The effects of Lampit (Bayer 2502) on the interaction of Trypanosoma cruzi with vertebrate cells in vitro. American Journal of Tropical Medicine and Hygiene, 26, 58-63.
22. Dvorak, J. A. & Hyde, T. P. (1973). Trypanosoma cruzi: Interaction with vertebrate cells in vitro. 1. Individual interactions at the cellular and subcellular levels. Experimental Parasitology, 34, 268-283.
23. Gelb, M. H., Jain, M. K. & Berg, O. G. (1994). Inhibition of phospholipase A2. FASEB Journal, 8, 916-924.
24. Glaser, K. B., Mobilio, D., Chang, J. Y. & Senko, N. (1993). Phospholipase A2 enzymes: Regulation and inhibition. Trends in Pharmacological Sciences, 14, 92-98.
25. Gonnert, R. & Bock, M. (1972). The effect of nifurtimox on Trypanosoma cruzi in tissue cultures. Arzneimittel Forschung, 22, 1582-1586.
26. Hall, B. F. & Joiner, K. A. (1991). Strategies of obligate intracellular parasites for evading host defences. Immunology Today, 12, A22-A27.
27. Hall, B. F., Webster, P., Ma, A. K., Joiner, K. A. & Andrews, N. W. (1992). Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: A role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm. Journal of Experimental Medicine, 176, 313-325.
28. Hyde, T. P. & Dvorak, J. A. (1973). Trypanosoma cruzi: Interaction with vertebrate cells in vitro. 2. Quantitative analysis of the penetration phase. Experimental Parasitology, 34, 284-294.
29. Ikeda, T., Nakakuma, H., Shionoya, H., Kawaguchi, T., Yamatsu, K. & Takatsuki, K. (1992). Ganglioside-induced inhibition of in vivo immune response in mice. Life Sciences, 51, 847-851.
30. Kopitz, J., von Reitzenstein, C., Muhl, C. & Cantz, M. (1994). Role of plasma membrane ganglioside sialidase of human neuroblastoma cells in growth control and differentiation. Biochemical and Biophysical Research Communications, 199, 1188-1193.
31. 2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Letters, 410, 49-53.
32. Laguens, R. P., Argel, M. I., Chambo, J., Storino, R. & Cabeza Meckert, P. M. (1994). Presence of antiheart and antiskeletal muscle glycolipid autoantibodies in the sera of patients with chagasic cardiopathy. Canadian Journal of Cardiology, 10, 769-776.
33. Leslie, C. C. (1997). Properties and regulation of cytosolic phospholipase A2. Journal of Biological Chemistry, 272, 16709-16712.
34. Lujan, H. D. & Bronia, D. H. (1994). Intermembrane lipid transfer during Trypanosoma cruzi-induced erythrocyle membrane destabilization. Parasitology, 108, 323-334.
35. Lujan, H. D., Paglini, P., Fretes, R., Fernandez, A., Fidelio, G. D. & Bronia, D. H. (1993). Effect of gangliosides on Trypanosoma cruzi infection in mice. Life Sciences, 53, L69-L73.
36. Marr, J. J. & Docampo, R. (1986). Chemotherapy for Chagas' disease: A perspective of current therapy and considerations for future research. Reviews of Infectious Diseases, 8, 884-903.
37. Murakami, M., Nakatani, Y., Atsumi, G., Inoue, K. & Kudo, I. (1997). Regulatory functions of phospholipase A2. Critical Reviews in Immunology, 17, 225-283.
38. Nakakuma, H., Kawaguchi, T., Koito, A., Hattori, T., Kagimoto, T. & Takatsuki, K. (1989). Inhibition of human immunodeficiency virus infection of human lymphocytes by gangliosides. Japanese Journal of Cancer Research, 80, 702-705.
39. Ortega-Barria, E. & Pereira, M. E. (1992). Entry of Trypanosoma cruzi into eukaryotic cells. Infectious Agents and Disease, 1, 136-145.
40. Rodriguez, A., Samoff, E., Rioult, M. G., Chung, A. & Andrews, N. W. (1996). Host cell invasion by trypanosomes requires lysosomes and microtubule/kinesin-mediated transport. Journal of Cell Biology, 134, 349-362.
41. Saffer, L. D. & Schwartzman, J. D. (1991). A soluble phospholipase of Toxoplasma gondii associated with host cell penetration. Journal of Protozoology, 38, 454-460.
42. Saffer, L. D., Long Krug, S. A. & Schwartzman, J. D. (1989). The role of phospholipase in host cell penetration by Toxoplasma gondii. American Journal of Tropical Medicine and Hygiene, 40, 145-149.
43. Schenkman, S. & Mortara, R. A. (1992), HeLa cells extend and internalize pseudopodia during active invasion by Trypanosoma cruzi trypomastigotes. Journal of Cell Sciences, 101, 895-905.
44. Schenkman, S., Robbins, E. S. & Nussenzweig, V. (1991). Attachment of Trypanosoma cruzi to mammalian cells requires parasite energy, and invasion can be independent of the target cell cytoskeleton. Injection and Immunity, 59, 645-654.
45. Scudder, P., Doom, J. P., Chuenkova, M., Manger, I. D. & Pereira, M. E. (1993). Enzymatic characterization of β-D galactoside α-2,3, trans-sialidase from Trypanosoma cruzi. Journal of Biological Chemistry, 268, 9886-9891.
46. Shinoda, S., Ishida, K., Oh, E. G., Sasahara, K., Miyoshi, S., Chowdhury, M. A. R. & Yasuda, T. (1993). Studies on hemolytic action of a hemolysin produced by Vibrio mimicus. Microbiology and Immunology, 37, 405-409.
47. Tardieux, I., Webster, P., Ravesloot, J., Boron, W., Lunn, J. A., Heuser, J. E. & Andrews, N. W. (1992). Lysosome recruitment and fusion are early events required for trypanosome invasion of mammalian cells. Cell, 71, 1117-1130.
48. Urbina, J. A., Payares, G., Molina, J., Sanoja, C., Liendo, A., Lazardi, K., Piras, M. M., Piras, R., Perez, N., Wincker, P. & Ryley, J. F. (1996). Cure of short- and long-term experimental Chagas' disease using D0870. Science, 273, 969-971.
49. Urbina, J. A., Payares, G., Contreras, L. M., Liendo, A., Sanoja, C., Molina, J., Piras, M., Piras, R., Perez, N., Wincker, P. & Loebenberg, D. (1998). Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: In vitro and in vivo studies. Antimicrobial Agents and Chemotherapy, 42, 1771-1777.
50. Vermelho, A. B. & Meirelles, M. N. (1994). Sialoglycoconjugates in Trypanosoma cruzi - host cell interaction: Possible biological models: A review. MemóRias do Instituto Oswaldo Cruz, 89, 69-79.
51. Vermelho, A. B., de Meirelles, M. de N., Pereira, M. C., Pohlentz, G. & Barreto Bergter, E. (1997). Heart muscle cells share common neutral glycosphingolipids with Trypanosoma cruzi. Acta Tropica, 64, 131-143.
52. Viotti, R., Vigliano, C., Armenti, H. & Segura, E. (1994). Treatment of chronic Chagas' disease with benznidazole: Clinical and serologic evolution of patients with long-term follow-up. American Heart Journal, 127, 151-162.
53. Zingales, B., Carniol, C., de Lederkremer, R. M. & Colli, W. (1987). Direct sialic acid transfer from a protein donor to glycolipids of trypomastigote forms of Trypanosoma cruzi. Molecular and Biochemical Parasitology, 26, 135-144.